Skip to main content
The Globe and Mail
Support Quality Journalism.
The Globe and Mail
First Access to Latest
Investment News
Collection of curated
e-books and guides
Inform your decisions via
Globe Investor Tools
per week
for first 24 weeks

Enjoy unlimited digital access
Enjoy Unlimited Digital Access
Get full access to
Just $1.99 per week for the first 24 weeks
Just $1.99 per week for the first 24 weeks
var select={root:".js-sub-pencil",control:".js-sub-pencil-control",open:"o-sub-pencil--open",closed:"o-sub-pencil--closed"},dom={},allowExpand=!0;function pencilInit(o){var e=arguments.length>1&&void 0!==arguments[1]&&arguments[1];select.root=o,dom.root=document.querySelector(select.root),dom.root&&(dom.control=document.querySelector(select.control),dom.control.addEventListener("click",onToggleClicked),setPanelState(e),window.addEventListener("scroll",onWindowScroll),dom.root.removeAttribute("hidden"))}function isPanelOpen(){return dom.root.classList.contains(}function setPanelState(o){dom.root.classList[o?"add":"remove"](,dom.root.classList[o?"remove":"add"](select.closed),dom.control.setAttribute("aria-expanded",o)}function onToggleClicked(){var l=!isPanelOpen();setPanelState(l)}function onWindowScroll(){window.requestAnimationFrame(function() {var l=isPanelOpen(),n=0===(document.body.scrollTop||document.documentElement.scrollTop);n||l||!allowExpand?n&&l&&(allowExpand=!0,setPanelState(!1)):(allowExpand=!1,setPanelState(!0))});}pencilInit(".js-sub-pencil",!1); // via darwin-bg var slideIndex = 0; carousel(); function carousel() { var i; var x = document.getElementsByClassName("subs_valueprop"); for (i = 0; i < x.length; i++) { x[i].style.display = "none"; } slideIndex++; if (slideIndex> x.length) { slideIndex = 1; } x[slideIndex - 1].style.display = "block"; setTimeout(carousel, 2500); } //

This July 15, 2011, photo shows Clorox brand products line the shelf of a supermarket in the East Village neighborhood of New York.

Mary Altaffer/The Associated Press

The pandemic has created a new corporate hierarchy of winners and losers.

We all know who the losers are. Any company in the travel and hospitality sector falls into that category. So do oil companies, real estate investment trusts and car manufacturers.

The winners are fulfilment companies like Inc., big box retailers such as Walmart Inc. and Costco Wholesale Corp., and any company that offers face-to-face online communication.

Story continues below advertisement

There’s also another category that some people tend to overlook. They are the companies that make products that everyone is desperately trying to buy these days – cleaners and sanitizers.

Have you tried to buy a container of disinfectant spray lately? Or a pack of sanitizing wipes? Forget it. Amazon has a notice on its website saying they’re all reserved for front-line workers. The suppliers can’t keep up with the demand.

One of the firms in this sweet spot is Clorox Co. (CLX-N), which recently reported its biggest sales increase in nearly a decade.

In addition to bleach, which was the company’s only product when it was launched back in 1913, Clorox now produces a wide range of disinfectants for both home and institutional use. They include disinfectant wipes, Spore Healthcare Defense Cleaner Disinfectant, Citrace Hospital Disinfectant & Deodorizer, and many more.

The company experienced an unprecedented 500-per-cent surge in demand for its key cleaning products after the virus hit. Despite moving to a 24/7 production schedule and sourcing more supply from third parties, it still couldn’t keep up.

“We acknowledge our products aren’t consistently in stock, and there’s more to do,” said chief executive Benno Dorer. “We put Clorox disinfecting wipes on store shelves every day and find that people scoop them up almost as soon as they’re delivered. But we are partnering with our retailers to serve consumers’ needs as best we can and expect continued meaningful movement in our ability to meet demand this summer. We are also making considerable investments to increase capacity for the mid-term, applying what we’ve learned from this crisis to be prepared for a surge in demand in the future.”

Clorox produces more than disinfectants. The briquettes you use on your barbeque may be from them (Kingsford). Your kitchen garbage bag may be one of their products (Glad). The product you pour in the sink to clean the drain may be theirs (Liquid-Plumr). Clorox also makes Pine-Sol, Hidden Valley Ranch salad dressings, Calm (a dietary supplement), Fresh Step cat litter, and more.

Story continues below advertisement

As you might expect, given the spike in demand for its products, Clorox is doing very well from a financial perspective. Third-quarter 2020 earnings released last month, showed sales growth of 15 per cent and a 31-per-cent increase in earnings per share.

The company reported net sales of almost US$1.8-billion for the three months to March 31, up from just under US$1.6-billion in the year-before period. Net earnings were US$241-million ($1.89 a share, fully diluted) compared with US$187-million (US$1.44) in the third quarter of fiscal 2019.

Year-to-date net cash provided by operations was US$806-million compared with US$603-million in the year-ago period, for an increase of 34 per cent.

The company increased its earnings forecast for the current fiscal year to US$6.70 to US$6.90 a diluted share.

Shortly after the results came out, Clorox announced a 5-per-cent increase in its quarterly dividend, to US$1.11 per share (US$4.44 annually). At Friday’s closing price of US$197.57, the shares yield 2.25 per cent at the new rate.

The main negative is that Clorox stock is not cheap. The shares are up by 28.7 per cent so far this year, from a close of US$153.54 on Dec. 31. At the current price, the trailing price-to-earnings ratio is 28.99 – not outrageous for a company whose earnings appear poised to grow, but not cheap either.

Story continues below advertisement

While I do not own the stock (wish I did), I recommend Clorox for current and long-term growth, and you also collect a reasonable dividend. However, given the high price you may wish to buy in tranches – perhaps one-third of your position now and the rest on dips below US$190.

Gordon Pape is editor and publisher of the Internet Wealth Builder and Income Investor newsletters.

Be smart with your money. Get the latest investing insights delivered right to your inbox three times a week, with the Globe Investor newsletter. Sign up today.

Coronavirus information
Coronavirus information
The Zero Canada Project provides resources to help you manage your health, your finances and your family life as Canada reopens.
Visit the hub

Your Globe

Build your personal news feed

  1. Follow topics and authors relevant to your reading interests.
  2. Check your Following feed daily, and never miss an article. Access your Following feed from your account menu at the top right corner of every page.

Follow the author of this article:

Follow topics related to this article:

View more suggestions in Following Read more about following topics and authors
Report an error Editorial code of conduct
Tickers mentioned in this story
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to If you want to write a letter to the editor, please forward to

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies